Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

ClinicalTrials.gov ID: NCT00097357

Public ClinicalTrials.gov record NCT00097357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 8:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blinded (BMS-562247 and Enoxaparin), Active-Controlled (Enoxaparin and Warfarin), Parallel-Arm, Dose-Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Study identification

NCT ID
NCT00097357
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,238 participants

Conditions and interventions

Interventions

  • Apixaban Drug
  • Enoxaparin Drug
  • Warfarin Drug
  • Enoxaparin Placebo Drug
  • Apixaban Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
Mar 1, 2010

2004 – 2005

United States locations

U.S. sites
72
U.S. states
27
U.S. cities
72
Facility City State ZIP Site status
Local Institution Birmingham Alabama
Local Institution Mobile Alabama
Local Institution Northport Alabama
Local Institution Phoenix Arizona
Local Institution Scottsdale Arizona
Local Institution Tucson Arizona
Local Institution Little Rock Arkansas
Local Institution Beverly Hills California
Local Institution Encinitas California
Local Institution Fountain Valley California
Local Institution La Jolla California
Local Institution La Mesa California
Local Institution Long Beach California
Local Institution Montclair California
Local Institution Oakland California
Local Institution Pasadena California
Local Institution Sacramento California
Local Institution San Bernardino California
Local Institution San Diego California
Local Institution Santa Monica California
Local Institution Torrance California
Local Institution Wildomar California
Local Institution Yuba City California
Local Institution Aurora Colorado
Local Institution Denver Colorado
Local Institution Hartford Connecticut
Local Institution Bay Pines Florida
Local Institution Brandon Florida
Local Institution Clearwater Florida
Local Institution DeLand Florida
Local Institution Fort Myers Florida
Local Institution Hollywood Florida
Local Institution Melbourne Florida
Local Institution Pensacola Florida
Local Institution Sarasota Florida
Local Institution St. Petersburg Florida
Local Institution Tallahassee Florida
Local Institution Winter Park Florida
Local Institution Atlanta Georgia
Local Institution Cumming Georgia
Local Institution Decatur Georgia
Local Institution Suwanee Georgia
Local Institution Boise Idaho
Local Institution Meridian Idaho
Local Institution Galesburg Illinois
Local Institution Springfield Illinois
Local Institution Wichita Kansas
Local Institution Lexington Kentucky
Local Institution Madisonville Kentucky
Local Institution Covington Louisiana
Local Institution Baltimore Maryland
Local Institution Newton Massachusetts
Local Institution Port Huron Michigan
Local Institution Jackson Mississippi
Local Institution Buffalo New York
Local Institution Charlotte North Carolina
Local Institution Monroe North Carolina
Local Institution Cincinnati Ohio
Local Institution Youngstown Ohio
Local Institution Tulsa Oklahoma
Local Institution Havertown Pennsylvania
Local Institution Philadelphia Pennsylvania
Local Institution Pittsburgh Pennsylvania
Local Institution Charleston South Carolina
Local Institution Austin Texas
Local Institution Dallas Texas
Local Institution Houston Texas
Local Institution Lubbock Texas
Local Institution San Antonio Texas
Local Institution Newport News Virginia
Local Institution Seattle Washington
Local Institution Marshfield Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00097357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2010 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00097357 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →